
|Articles|October 1, 2002
Supplements and Featured Publications
- Cardiorenal Differences Among NSAIDs and Coxibs: Real-World Experience
- Volume 8
- Issue 15 Suppl
Differences Between COX-2-Specific Inhibitors: Clinical and Economic Implications
Author(s)Edmund H. Sonnenblick, MD
Advertisement
Articles in this issue
over 23 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Congress Unveils Massive Funding Bill to Avert Shutdown
2
Gates Foundation, OpenAI Launch $50M AI Health Initiative in Africa
3
By Improving Sleep, TNX-102 SL Reduces Pain and Fatigue in Fibromyalgia
4
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval
5




























































